Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Quarterly results Credit agrmnt [a] Appointed director
|
Element Solutions Inc (PAH)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/28/2019 |
8-K
| Quarterly results |
07/20/2018 |
8-K
| Appointed a new director
Docs:
|
"UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : July 19, 2018 Delaware 001-36272 37-1744899 1450 Centrepark Boulevard Suite 210 West Palm Beach, Florida 33401 Registrant's telephone number, including area code: 207-9600 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commen...",
"Stock Purchase Agreement, between Platform and Purchaser. Disclosure schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Stock Purchase Agreement, as filed, identifies such schedules and exhibits, including the general nature of their contents. Platform agrees to furnish a copy of any omitted attachment to the SEC on a confidential basis upon request",
"Platform Specialty Products Corporation Announces Sale of Arysta LifeScience",
"Platform Specialty Products Corporation Announces Corporate Name Change Following Completion of the Sale of Arysta LifeScience, Provides Pro Forma Financial Outlook and Announces Authorization for up to $750 Million in Share Repurchases",
"Selected slides from the investor presentation (furnished only)" |
|
12/16/2015 |
8-K
| Appointed a new director |
|
|